The high court had given the company six weeks for retesting.
Portfolios were distributed 2 weeks after the MVA govt was sworn-in. Shiv Sena's Eknath Shinde will be home minister while NCP's Jayant Patil will be finance minister.
The S&P BSE Sensex ended down 371 points at 24,966 and the Nifty50 closed 101 points lower at 7,615.
Broader markers outperformed their larger peers.
Fear factors weights on markets, Sensex, Nifty struggle to keep pace.
Most Asian markets ended with gains.
The 30-share Sensex ended up 292 points at 29,571 and the 50-share Nifty closed up 75 points at 8,910.
Rate-sensitive sectors like banks, auto and realty witnessed strong buying demand in trades today
The Sensex ended lower on unfavourable cues.
Market breadth continued to remain strong, with 1899 gainers and 674 losers on the BSEs.
Ranbaxy did its maiden public issue in 1973.
This is not the first time Gujarat Cooperative Milk Marketing Federation that owns brand Amul has chosen an unconventional method to protect its brand.
Dilip Shanghvi has never tried to be everything to everybody.
The S&P BSE Sensex ended 46 points lower at 24,824 and Nifty50 settled at 7,555, down by 8 points after hitting intra-day high of 7,600.45.
Nestle is sure to go for a relaunch of the noodles soon enough with an advertising blitz,
It hopes to turn around Ranbaxy within four years of closing the deal by improving efficiency and resolving all regulatory issues
Business of retail, food and beverages at duty-free shops in India was estimated to have a potential of $3.5 billion by 2021.
Jammu and Kashmir MLA Ramesh Arora wants momos banned, but are they really unhygienic and harmful?
While the two high-profile exits in pharmaceutical and telecom have raised concerns over regulatory hassles in the country, Japanese investors are still keen to tap into India's consumer growth story and many more merger and acquisition deals are in the offing in this space.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances